Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The contribution of genetics and epigenetics to MAFLD susceptibility.

Hepatology international - 1 Oct 2024

Moretti Vittoria, Romeo Stefano, Valenti Luca

Abstract excerpt

Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common liver disease worldwide. The risk of developing MAFLD varies among individuals, due to a combination of environmental inherited and acquired genetic factors. Genome-wide association and next-generation sequencing studies are leading to the discovery of the common and rare genetic determinants of MAFLD. Thanks to the great advances in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endoplasmic Reticulum Stress and Disease
Share to Epigenesis, Genetic
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Lipid metabolism and biosynthesis

Share to Liver Disease Diagnosis and Treatment

Share to Non-alcoholic Fatty Liver Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 38662298
DOI: 10.1007/s12072-024-10667-5
PMCID: PMC11450136

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The contribution of genetics and epigenetics to MAFLD susceptibility.PMID 38662298Read ↗

Update on genetics and epigenetics in metabolic associated fatty liver diseaseSemantic proximity Read ↗

An Update in Epigenetics in Metabolic-Associated Fatty Liver DiseaseSemantic proximity Read ↗

Genetics and epigenetics purpose in nonalcoholic fatty liver disease.Semantic proximity Read ↗

Advances in genetic variation in metabolism-related fatty liver diseaseSemantic proximity Read ↗

Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease.Semantic proximity Read ↗

Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease.Semantic proximity Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Genomic Signatures of MASLD: How Genomics Is Redefining Our Understanding of Metabolic Liver DiseaseSemantic proximity Read ↗

Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read ↗

Genetics and epigenetics of NAFLD and NASH: Clinical impact.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.